Stay updated on Relamorelin in Diabetic Gastroparesis Clinical Trial
Sign up to get notified when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.
Latest updates to the Relamorelin in Diabetic Gastroparesis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedBoth additions and deletions are minor wording changes: they clarify how PubMed publications are populated and update the revision label, without altering study content, endpoints, or participant-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedDeleted the site-wide notice stating that information may not be up to date due to government funding lapse and that the NIH Clinical Center is open (updates at opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check42 days agoChange DetectedNo additions or deletions to the study content were detected; the updates appear to be minor UI/layout changes that do not impact the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check71 days agoChange DetectedSummary: Updated operating status notice and version from v3.1.0 to v3.2.0. The page now includes a government funding lapse notice and directs users to operating-status sources.SummaryDifference2%
- Check78 days agoChange DetectedUpdated version to v3.1.0 and removed several drug-safety topic items (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with a prior version reference v3.0.2 still listed in deletions.SummaryDifference0.3%
- Check92 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.1%
Stay in the know with updates to Relamorelin in Diabetic Gastroparesis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.